News

Prof. Caitriona O’Driscoll, coordinator of the GENEGUT project, was recently interviewed by HNN 3.0 as part of their Horizon Health Impact Success Stories series.

On 25–26 June 2025, the GENEGUT consortium convened for its 7th General Assembly meeting, hosted by Uppsala University (UU) in Sweden. The two-day meeting marked project month 33 and brought together over 30 participants representing all nine project partners.

Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce CarboHyde, based in Budapest, Hungary.

Our improved 3D model plays a big role in the GENEGUT project as a testing platform to check if the new nano-based treatments we’re developing are safe and effective in IBD treatment.

Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce i3S – Institute of Science and Innovation in Health, based in Porto, Portugal.

To mark World IBD Day 2025, the GENEGUT project is proud to share a special interview featuring voices from across the IBD community. This year’s campaign, “IBD Has No Borders: Breaking Taboos, Talking About It”, launched by EFCCA, GENEGUT’s project partner, shines a spotlight on the ongoing stigma and silence that many people living with IBD still face today.